Shelly Bowers Hayes, MD

I would like to give you a little background about myself, my training and my approach to treating cancer patients.

I did my undergraduate work at the University of Pennsylvania, majoring in bioengineering. I attended medical school at Temple University and did my residency in radiation oncology at the Fox Chase Cancer Center where I served as chief resident in 2005-06. During my training, I participated in many clinical research projects which have been published in various peer reviewed journals and presented at our national meeting of radiation oncologists. My research endeavors earned me the RSNA Roentgen Resident/Fellow Research Award in 2006.

Upon finishing my residency, I entered private practice, joining a radiation oncology group in Richmond, VA where I spent two years. During that time, I attended training in Pittsburgh, PA, becoming certified on the gamma knife, a radiosurgery treatment unit to treat benign and malignant tumors and other conditions in the brain. While practicing in Richmond, I worked in conjunction with a large neurosurgery group and treated many types of central nervous system tumors. I became board-certified in radiation oncology in 2008. I am now returning to Fox Chase as the Director of the Fox Chase Cancer Center- Buckingham radiation facility in Bucks County.

I am excited to be part of the Fox Chase family once again. I chose to return to Fox Chase because of the outstanding care we provide. Not only do we offer treatments with the latest, most cutting edge technology, but we do so in an evidence-based manner. We enroll patients on clinical trials, both Fox Chase trials and cooperative group trials, in order to scientifically analyze the most effective treatments. We maintain databases for various disease sites so as to critically analyze our results and make changes in treatment regimens to continually improve our outcomes.

I treat all types of cancer, but have a particular interest in breast, gynecologic, prostate and lung malignancies. I also have an interest in brain and spinal cord tumors. I have experience in using intensity modulated radiation therapy, image-guided radiation therapy, stereotactic radiosurgery and stereotactic body radiotherapy to treat many different cancers.

My personal philosophy with regards to treating cancer is a patient focused approach. I believe that each patient has a unique set of needs and concerns. I will create an individualized treatment plan to meet those needs. I will work in conjunction with your other physicians to coordinate and streamline your care.

Video

Introductory Video of Dr. Hayes

Radiation Oncology
Director,
Fox Chase Cancer Center
Buckingham

2365 Heritage Center Drive
Furlong, PA 18925

New patients can request an appointment online or call 215-794-2700.

For general information, call:
1-888-FOX CHASE.
An oncology certified nurse will assist you.

Expertise:

CyberKnife training; Lung Cancer, Breast Cancer, gynecological cancers;CNS malignancies; IMRT; stereotactic body radiation and stereotactic radiosurgery

Education:

MD, Temple University School of Medicine,  Philadelphia, PA, 2002;
BSE University of Pennsylvania, Bioengineering, Philadelphia, PA, 1995

Residency:

Chief Resident Fox Chase Cancer Center 2005/06;
Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, 2003 – 2007;
Preliminary Medicine Resident, Albert Einstein Medical Center, Philadelphia, PA, 2003

Certifications:

American Board of Radiology
Gamma Knife Radiosurgery
CyberKnife Trained

Honors and Awards

Chief Resident Fox Chase Cancer Center 2005/06;
2006 RSNA Roentgen Resident/Fellow Research Award

Professional Societies:

American Society for Therapeutic Radiology and Oncology;
American Society of Clinical Oncology

Publications:

Presentations and Publications

Research Interests:

I am interested in the effects of respiration on tumor motion in the lung, breast, and abdomen and in utilizing image-guidance to improve the accuracy and efficacy of radiation to these areas. I have also studied parameters for treatment decisions for salvage radiation after prostatectomy for recurrent prostate cancer and the risk of lymphedema in breast cancer patients treated with radiation after lumpectomy.